We are live on ! Find out more
EDIT icon

Editas Medicine

215 hedge funds and large institutions have $1.15B invested in Editas Medicine in 2018 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 73 increasing their positions, 56 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

84% more first-time investments, than exits

New positions opened: 46 | Existing positions closed: 25

49% more call options, than puts

Call options by funds: $40.4M | Put options by funds: $27.1M

30% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 56

11% more capital invested

Capital invested by funds: $1.03B → $1.15B (+$119M)

9% more funds holding

Funds holding: 197215 (+18)

1.62% more ownership

Funds ownership: 66.44%68.05% (+1.6%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

Holders
215
Holders Change
+18
Holders Change %
+9.14%
% of All Funds
4.92%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
46
Increased
73
Reduced
56
Closed
25
Calls
$40.4M
Puts
$27.1M
Net Calls
+$13.2M
Net Calls Change
+$651K
Name Holding Trade Value Shares
Change
Change in
Stake
AIG
76
American International Group
New York
$1.06M +$213K +6,025 +25%
USAA
77
United Services Automobile Association
Texas
$1.02M +$21K +592 +2%
Commonwealth Equity Services
78
Commonwealth Equity Services
Massachusetts
$975K +$57.8K +1,632 +6%
FWM
79
Focused Wealth Management
New York
$946K +$547K +15,439 +141%
ProShare Advisors
80
ProShare Advisors
Maryland
$926K -$19.7K -555 -2%
Simplex Trading
81
Simplex Trading
Illinois
$891K -$219K -6,178 -20%
Creative Planning
82
Creative Planning
Kansas
$890K -$43.4K -1,227 -5%
CRWM
83
Castle Rock Wealth Management
California
$847K +$233K +6,575 +39%
PPA
84
Parametric Portfolio Associates
Washington
$828K +$283 +8 +0%
AAMU
85
Amundi Asset Management US
Massachusetts
$795K +$786K +22,200 New
RJFSA
86
Raymond James Financial Services Advisors
Florida
$791K +$374K +10,556 +92%
Schroder Investment Management Group
87
Schroder Investment Management Group
United Kingdom
$780K +$770K +21,753 New
MIM
88
MetLife Investment Management
New Jersey
$758K +$163K +4,611 +28%
TD Asset Management
89
TD Asset Management
Ontario, Canada
$744K +$10.6K +300 +1%
CIM
90
CIM Investment Management
Pennsylvania
$673K
TAM
91
Tocqueville Asset Management
New York
$653K +$287K +8,100 +80%
VOYA Investment Management
92
VOYA Investment Management
Georgia
$640K +$74.7K +2,110 +13%
State Board of Administration of Florida Retirement System
93
State Board of Administration of Florida Retirement System
Florida
$603K +$37.5K +1,060 +7%
DADC
94
D.A. Davidson & Co
Montana
$595K +$17.8K +502 +3%
MSL
95
Mackay Shields LLC
New York
$595K +$588K +16,600 New
ADEF
96
Adams Diversified Equity Fund
Maryland
$573K +$567K +16,000 New
CWM
97
Cornerstone Wealth Management
Missouri
$570K +$747K +21,085 New
AQR Capital Management
98
AQR Capital Management
Connecticut
$566K
MLICM
99
Metropolitan Life Insurance Company (MetLife)
New York
$536K +$113K +3,192 +27%
GT
100
Glenmede Trust
Pennsylvania
$529K +$345K +9,745 +195%

EDIT Hedge Fund Activity: Q2 2018 in Review

215 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q2 2018, worth a combined $1.15B — up 11% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 46 funds opened new EDIT positions and 25 closed out — a net gain of 21 holders — while 73 added to existing stakes and 56 trimmed.

The largest buyer was BlackRock, adding an estimated $20.9M. The largest seller was Fidelity Investments, cutting an estimated $40.7M.

  • 215 institutional investors held Editas Medicine (EDIT) as of Q2 2018, up from 197 in Q1 2018.
  • Funds reported $1.15B of Editas Medicine stock for Q2 2018, up 11% quarter-over-quarter.
  • 46 funds opened new Editas Medicine positions in Q2 2018 and 25 closed out, a net change of +21 holders.
  • The largest Editas Medicine buyer in Q2 2018 was BlackRock, an estimated $20.9M added.
  • The largest Editas Medicine seller in Q2 2018 was Fidelity Investments, an estimated $40.7M sold.

Based on aggregated 13F filings for Q2 2018.